A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes

A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes

There is a pressing need for a ubiquitously expressed antigen or receptor on the tumor surface for successful mitigation of the deleterious side effects of chemotherapy. Phosphatidylserine (PS), normally constrained to the intracellular surface, is exposed on the external surface of tumors and most...

Full description

Bibliographic Details
Main Authors: Manjarika De, Sneha Ghosh, Triparna Sen, Md. Shadab, Indranil Banerjee, Santanu Basu, Nahid Ali
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
phosphatidylserine
phosphatidylcholine-stearylamine
liposomes
apoptosis
tumor inhibition
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253117302834

Internet

http://www.sciencedirect.com/science/article/pii/S2162253117302834

Similar Items